XML 33 R16.htm IDEA: XBRL DOCUMENT v3.25.1
Note 8 - Income Taxes
12 Months Ended
Dec. 31, 2024
Notes to Financial Statements  
Income Tax Disclosure [Text Block]

8.    Income Taxes

 

The income tax expense included in the Consolidated Statements of Operations consists of the following:

 

 

Years Ended December 31,

 

(in thousands)

 

2024

  

2023

 

Continuing Operations:

 

  

 

Current:

 

  

 

Federal

 $(7) $(24)

State

     (2)

Total Current

  (7)  (26)

Deferred:

        

Federal

     (1,072)

State

      

Total Deferred

     (1,072)

Total Continuing Operations

 $(7) $(1,098)

 

  

 

Discontinued Operation:

 

  

 

Current:

 

  

 

Federal

 $  $ 

State

      

Total Current

      

Deferred:

 

  

 

Federal

      

State

      

Total Deferred

      

 

  

 

Total Discontinued Operation

 $  $ 

 

  

 

Total Income Tax Expense

 $(7) $(1,098)

 

The reconciliation of the federal statutory income tax rate to the Company’s effective tax rate based upon the total income tax provision from continuing operations is as follows:

 ​

 

Years Ended December 31,

 

 

2024

  

2023

 

 

  

 

Federal statutory rate

  21.0%  21.0%

Permanent non-taxable income

  (3.5)%  0.2%

Business credits

  21.3%  2.8%

State taxes, net of federal benefit

  0.0%  (0.1)%

Valuation allowance

  (38.7)%  (68.6)%

Other

  (0.6)%  (0.1)%

  (0.5)%  (44.8)%

 

At December 31, 2024 and 2023, the deferred tax assets (liabilities) from continuing operations were comprised of the following:

 ​

  

Years Ended December 31,

 

(in thousands)

  

2024

  

2023

 

  

  

 

Deferred Tax Assets:

  

  

 

Inventories

 $202  $254 

Accrued employees' compensation and benefits costs

  316   362 

Postretirement adjustment (accumulated other comprehensive loss)

  566   635 

Accrued litigation settlement

  128   39 

State credit carryforwards

  157   177 

Federal credit carryforwards

  302    

Federal net operating loss carryforward

  482   1,493 

Bad debt reserve

  3   26 

Warranty reserve

  70   114 

Research and experimentation expenses

  2,217   751 

Customer accruals

  156   344 

Sec 163(j) disallowed interest

  46   83 

Other

  1   1 

Total deferred tax assets

  4,646   4,279 

Valuation allowance

  (3,727)  (3,145)

Net deferred tax assets

  919   1,134 

     

 

Deferred tax liabilities:

         

Prepaid expenses

  (78)  (71)

Property, plant and equipment

  (841)  (853)

Other receivable - insurance proceeds

     (210)

Total deferred tax liabilities

  (919)  (1,134)

Net deferred tax assets

 $  $ 

 

In assessing the ability of the Company to realize the benefit of the deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. Based upon the level of historical pre-tax income, as well as projections of future taxable income over the periods which deferred tax assets are deductible, management determined that it is more likely than not that the Company may not realize the net deferred tax assts recorded as of December 31, 2024. Accordingly, a valuation allowance of $3,727,000, an increase of approximately $582,000 from the valuation allowance of $3,145,000 as of  December 31, 2023, was recorded against net deferred tax assets as of  December 31, 2024.  The federal net operating loss carryforward amount is approximately $2,291,000 as of December 31, 2024 ($7,100,000 as of December 31, 2023) and has no expiration date. The Company has a New York state tax credit carryforward of approximately $198,000 as of  December 31, 2024 ($219,000 as of  December 31, 2023), which begins to expire in 2025.

 

There are no uncertain tax positions or unrecognized tax benefits for 2024 and 2023. The Company is subject to routine audits of its tax returns by the Internal Revenue Service and various state taxing authorities. The 2021 through 2024 federal and 2020 through 2024 state tax returns remain subject to examination.